JAMA Review Supports COVID Vaccines for 2026–27—but Safety Signals and High-Risk Observational Evidence Complicate the Picture
JAMA Review Supports COVID Vaccines for 2026–27—but Safety Signals and High-Risk Observational Evidence Complicate the Picture